United States Neuromyelitis Optica Drug Market Report 2017

January 2018 | 112 pages | ID: U59EBDCD23CEN
QYResearch

Abstracts

In this report, the United States Neuromyelitis Optica Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Neuromyelitis Optica Drug in these regions, from 2012 to 2022 (forecast).

United States Neuromyelitis Optica Drug market competition by top manufacturers/players, with Neuromyelitis Optica Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer
• Fresenius
• TEVA
• Sandoz
• Intas
• Gyjtrs
• Nang Kuang
• Tianjin Kingyork
• Baxter
• CSL
• Grifols
• Octapharma
• CBOP

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Glucocorticoids
• Immunoglobulin
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Acute Attack
• Remission Prophylactic Treatment

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Neuromyelitis Optica Drug Market Report 2017

1 NEUROMYELITIS OPTICA DRUG OVERVIEW

1.1 Product Overview and Scope of Neuromyelitis Optica Drug
1.2 Classification of Neuromyelitis Optica Drug by Product Category
  1.2.1 United States Neuromyelitis Optica Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Neuromyelitis Optica Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Glucocorticoids
  1.2.4 Immunoglobulin
  1.2.5 Other
1.3 United States Neuromyelitis Optica Drug Market by Application/End Users
  1.3.1 United States Neuromyelitis Optica Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Acute Attack
  1.3.3 Remission Prophylactic Treatment
1.4 United States Neuromyelitis Optica Drug Market by Region
  1.4.1 United States Neuromyelitis Optica Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Neuromyelitis Optica Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Neuromyelitis Optica Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Neuromyelitis Optica Drug Status and Prospect (2012-2022)
  1.4.5 New England Neuromyelitis Optica Drug Status and Prospect (2012-2022)
  1.4.6 The South Neuromyelitis Optica Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Neuromyelitis Optica Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Neuromyelitis Optica Drug (2012-2022)
  1.5.1 United States Neuromyelitis Optica Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Neuromyelitis Optica Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES NEUROMYELITIS OPTICA DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Neuromyelitis Optica Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Neuromyelitis Optica Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Neuromyelitis Optica Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Neuromyelitis Optica Drug Market Competitive Situation and Trends
  2.4.1 United States Neuromyelitis Optica Drug Market Concentration Rate
  2.4.2 United States Neuromyelitis Optica Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neuromyelitis Optica Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Neuromyelitis Optica Drug Sales and Market Share by Region (2012-2017)
3.2 United States Neuromyelitis Optica Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Neuromyelitis Optica Drug Price by Region (2012-2017)

4 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Neuromyelitis Optica Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Neuromyelitis Optica Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Neuromyelitis Optica Drug Price by Type (2012-2017)
4.4 United States Neuromyelitis Optica Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NEUROMYELITIS OPTICA DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Neuromyelitis Optica Drug Sales and Market Share by Application (2012-2017)
5.2 United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NEUROMYELITIS OPTICA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Pfizer
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Fresenius
  6.2.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Fresenius Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 TEVA
  6.3.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 TEVA Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sandoz
  6.4.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sandoz Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Intas
  6.5.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Intas Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Gyjtrs
  6.6.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Gyjtrs Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Nang Kuang
  6.7.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Nang Kuang Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Tianjin Kingyork
  6.8.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Baxter
  6.9.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Baxter Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 CSL
  6.10.2 Neuromyelitis Optica Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 CSL Neuromyelitis Optica Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Grifols
6.12 Octapharma
6.13 CBOP

7 NEUROMYELITIS OPTICA DRUG MANUFACTURING COST ANALYSIS

7.1 Neuromyelitis Optica Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neuromyelitis Optica Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neuromyelitis Optica Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neuromyelitis Optica Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NEUROMYELITIS OPTICA DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Neuromyelitis Optica Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Neuromyelitis Optica Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Neuromyelitis Optica Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Neuromyelitis Optica Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neuromyelitis Optica Drug
Figure United States Neuromyelitis Optica Drug Market Size (K Units) by Type (2012-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Glucocorticoids Product Picture
Figure Immunoglobulin Product Picture
Figure Other Product Picture
Figure United States Neuromyelitis Optica Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Neuromyelitis Optica Drug by Application in 2016
Figure Acute Attack Examples
Table Key Downstream Customer in Acute Attack
Figure Remission Prophylactic Treatment Examples
Table Key Downstream Customer in Remission Prophylactic Treatment
Figure United States Neuromyelitis Optica Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuromyelitis Optica Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Neuromyelitis Optica Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Neuromyelitis Optica Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Neuromyelitis Optica Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuromyelitis Optica Drug Sales Share by Players/Suppliers
Figure 2017 United States Neuromyelitis Optica Drug Sales Share by Players/Suppliers
Figure United States Neuromyelitis Optica Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Neuromyelitis Optica Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Neuromyelitis Optica Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Neuromyelitis Optica Drug Revenue Share by Players/Suppliers
Figure 2017 United States Neuromyelitis Optica Drug Revenue Share by Players/Suppliers
Table United States Market Neuromyelitis Optica Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Neuromyelitis Optica Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Neuromyelitis Optica Drug Market Share of Top 3 Players/Suppliers
Figure United States Neuromyelitis Optica Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Neuromyelitis Optica Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Neuromyelitis Optica Drug Product Category
Table United States Neuromyelitis Optica Drug Sales (K Units) by Region (2012-2017)
Table United States Neuromyelitis Optica Drug Sales Share by Region (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Share by Region (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Region in 2016
Table United States Neuromyelitis Optica Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Neuromyelitis Optica Drug Revenue Share by Region (2012-2017)
Figure United States Neuromyelitis Optica Drug Revenue Market Share by Region (2012-2017)
Figure United States Neuromyelitis Optica Drug Revenue Market Share by Region in 2016
Table United States Neuromyelitis Optica Drug Price (USD/Unit) by Region (2012-2017)
Table United States Neuromyelitis Optica Drug Sales (K Units) by Type (2012-2017)
Table United States Neuromyelitis Optica Drug Sales Share by Type (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Share by Type (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Type in 2016
Table United States Neuromyelitis Optica Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Neuromyelitis Optica Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neuromyelitis Optica Drug by Type (2012-2017)
Figure Revenue Market Share of Neuromyelitis Optica Drug by Type in 2016
Table United States Neuromyelitis Optica Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Growth Rate by Type (2012-2017)
Table United States Neuromyelitis Optica Drug Sales (K Units) by Application (2012-2017)
Table United States Neuromyelitis Optica Drug Sales Market Share by Application (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Application (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Market Share by Application in 2016
Table United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2012-2017)
Figure United States Neuromyelitis Optica Drug Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Pfizer Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Fresenius Basic Information List
Table Fresenius Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Fresenius Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Fresenius Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table TEVA Basic Information List
Table TEVA Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure TEVA Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure TEVA Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure TEVA Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Sandoz Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Sandoz Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Intas Basic Information List
Table Intas Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Intas Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Intas Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Intas Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Gyjtrs Basic Information List
Table Gyjtrs Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Gyjtrs Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Gyjtrs Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Gyjtrs Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Nang Kuang Basic Information List
Table Nang Kuang Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Nang Kuang Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Nang Kuang Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Nang Kuang Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Tianjin Kingyork Basic Information List
Table Tianjin Kingyork Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tianjin Kingyork Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Tianjin Kingyork Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Tianjin Kingyork Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Baxter Basic Information List
Table Baxter Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Baxter Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure Baxter Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure Baxter Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table CSL Basic Information List
Table CSL Neuromyelitis Optica Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Neuromyelitis Optica Drug Sales Growth Rate (2012-2017)
Figure CSL Neuromyelitis Optica Drug Sales Market Share in United States (2012-2017)
Figure CSL Neuromyelitis Optica Drug Revenue Market Share in United States (2012-2017)
Table Grifols Basic Information List
Table Octapharma Basic Information List
Table CBOP Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neuromyelitis Optica Drug
Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug
Figure Neuromyelitis Optica Drug Industrial Chain Analysis
Table Raw Materials Sources of Neuromyelitis Optica Drug Major Players/Suppliers in 2016
Table Major Buyers of Neuromyelitis Optica Drug
Table Distributors/Traders List
Figure United States Neuromyelitis Optica Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Neuromyelitis Optica Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Neuromyelitis Optica Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Neuromyelitis Optica Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Neuromyelitis Optica Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Neuromyelitis Optica Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources